# Improve PAD PERformance With METformin

> **NCT03054519** · PHASE3 · COMPLETED · sponsor: **Northwestern University** · enrollment: 203 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03054519
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-23
- **Primary completion:** 2025-08-20
- **Final completion:** 2025-11-01
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054519, "Improve PAD PERformance With METformin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03054519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*